Clinical Trial Update: Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Ixmyelocel-T in patients with osteonecrosis of the femoral head has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Ixmyelocel-T (Ixmyelocel-T)

Snippet

Sponsor: Vericel Corporation | Conditions: Osteonecrosis | Phase 3 | Status: COMPLETED